Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corp (THC) operates a national network of hospitals and ambulatory centers, delivering acute care and technology-driven healthcare solutions. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and operational milestones. Stay informed about strategic initiatives shaping this diversified provider's role in the evolving healthcare sector.
Access comprehensive coverage of Tenet's press releases including earnings reports, strategic alliances, facility expansions, and regulatory updates. Our curated collection simplifies tracking the company's market position while maintaining strict editorial neutrality. Key focus areas include hospital operations, ambulatory service growth, and Conifer Health Solutions' performance.
This resource serves both casual observers and professional analysts seeking unfiltered access to primary source materials. Bookmark this page for centralized updates on Tenet Healthcare's official communications and third-party analysis. Monitor industry trends and corporate announcements affecting this leading healthcare services organization.
Tenet Healthcare (NYSE: THC) priced a private offering upsized to $2.25 billion of notes on November 3, 2025: $1.5 billion 5.500% senior secured first lien notes due November 15, 2032 and $0.75 billion 6.000% senior notes due November 15, 2033.
Closing is expected on November 18, 2025. Net proceeds, with cash on hand, will redeem all $1.5 billion outstanding 6.250% second lien notes due February 2027 and partially redeem $0.75 billion of 6.125% senior notes due October 2028. First lien notes are secured; senior notes are unsecured and will be offered only to qualified institutional buyers or outside U.S. persons under Regulation S.
Tenet Healthcare (NYSE: THC) announced private placements of $1.5 billion of senior secured first lien notes due 2032 and $0.5 billion of senior notes due 2033 to refinance $2.0 billion of outstanding notes.
The first lien notes will be guaranteed by certain subsidiaries and secured by a pledge of subsidiary ownership interests; the senior notes will be unsecured and structurally subordinated to subsidiary liabilities. Offerings are private to QIBs and non-U.S. persons under Rule 144A and Regulation S and are subject to pricing and customary closing conditions.
Tenet (NYSE: THC) reported third-quarter 2025 results with Q3 net income $342M ($3.86 diluted) and Adjusted diluted EPS $3.70, up 26.3% year-over-year. Consolidated Adjusted EBITDA was $1.099B, up 12.4% versus Q3 2024; Ambulatory Adjusted EBITDA was $492M, up 12.1%.
Year-to-date free cash flow was $2.163B, operating cash flow $2.809B, and net debt/Adjusted EBITDA improved to 2.30x. Tenet repurchased 0.6M shares for $93M in Q3 and 7.8M shares for $1.188B year-to-date. Management raised FY 2025 Adjusted EBITDA outlook to $4.47B–$4.57B (midpoint +$50M).
Tenet Healthcare (NYSE:THC) has scheduled the release of its Q3 2025 financial results for Tuesday, October 28, 2025, before market opening. The company will host a conference call at 9:30 a.m. CT (10:30 a.m. ET) to discuss the results. Investors can access both the live webcast and audio archive through Tenet's investor relations website.
Tenet Healthcare (NYSE:THC) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation is scheduled for September 3, 2025, at 9:30 a.m. Eastern Time.
Investors can access the live webcast and audio archive through Tenet's investor relations website. The replay will remain available for 30 days following the presentation.
Tenet Healthcare (NYSE:THC) and its subsidiary USPI have been named foundational sponsors of the American Association of Orthopaedic Surgeons' (AAOS) inaugural Launchpad Program. The 20-month initiative is designed to support postgraduate year 5 (PGY5) orthopaedic surgery residents in their transition from residency to practice.
The program, launched as a pilot at the AAOS Annual Meeting in March 2025, will support three cohorts of PGY5 resident members over the next three and a half years. It focuses on fellowship navigation, preparation for American Board of Orthopaedic Surgery examinations, and building foundations for long-term success. AAOS plans to expand the program to include all PGY4 and PGY5 residents after the pilot phase.
Tenet Healthcare (NYSE:THC) reported strong Q2 2025 results with significant growth across key metrics. Net income reached $288 million ($3.14 per diluted share), while Adjusted EBITDA increased 18.6% to $1.121 billion with a 21.3% margin.
The company's Ambulatory Care segment showed robust performance with Adjusted EBITDA of $498 million, up 11.4% year-over-year. The Hospital segment delivered strong results with Adjusted EBITDA of $623 million, benefiting from favorable payer mix and higher acuity services.
Notably, the Board authorized a $1.5 billion increase to the share repurchase program. Tenet raised its FY 2025 outlook, now expecting Adjusted EBITDA between $4.40-$4.54 billion, a $395 million increase at the midpoint.
Tenet Healthcare Corporation (NYSE: THC) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company's presentation is scheduled for Tuesday, May 13, 2025, at 1:40 p.m. Eastern time. Investors and interested parties can access the live webcast through Tenet's investor relations website at www.tenethealth.com/investors. A replay of the presentation will remain available on the website for 30 days following the event.
Tenet Healthcare reported strong Q1 2025 financial results, with net income of $406 million ($4.27 per diluted share) and Adjusted EBITDA of $1.163 billion, marking a 13.6% increase from Q1 2024. The company's Ambulatory Care segment showed impressive growth with a 15.7% increase in Adjusted EBITDA to $456 million.
Key highlights include:
- Adjusted diluted EPS increased 35.4% to $4.36
- Strong cash flow of $815 million from operations
- Same-hospital admissions grew 4.4%
- Ambulatory segment revenue increased 20%
The company's 2025 outlook projects net operating revenues between $20.6-21.0 billion and Adjusted EBITDA of $3.975-4.175 billion. Tenet maintains a strong operational position with 520 ambulatory surgery centers and 25 surgical hospitals across 37 states, demonstrating continued expansion in high-quality specialty care delivery.
FAQ
What is the current stock price of Tenet Healthcare (THC)?
What is the market cap of Tenet Healthcare (THC)?
